Skip to main content
Clinical Trials/ITMCTR2024000174
ITMCTR2024000174
Not yet recruiting
Early Phase 1

Study on the effect of acupuncture on improving chronic pain with anxiety by regulating cortical excitability

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine0 sitesTBD

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Chronic neck pain with mild to moderate anxiety disorders
Sponsor
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\) Aged 18\-60 years old;
  • 2\) Healthy volunteers: no physical discomfort or underlying diseases in the past 1 month; Hamilton anxiety scale score HAMA\-14\=7 points;
  • 3\) Patients with chronic neck pain and anxiety: need to meet the diagnostic criteria for chronic neck pain and anxiety; VAS score \> 3 and 8\< HAMA\-14 score \=20;
  • 4\) no history of needle faintness;
  • 5\) No peripheral stimulation intervention (such as acupuncture, peripheral electrical stimulation, etc.) and central stimulation (such as rTMS, tDCS, etc.) in the past three months;
  • 6\) Volunteer to participate in the study and sign the informed consent.

Exclusion Criteria

  • 1\) Patients with cervical spondylosis without cervical pain, or patients without cervical pain as the main complaint; Other types of cervical spondylosis were excluded through clinical manifestations and X\-ray examinations.
  • 2\) Have violent behavior, psychotic symptoms, or have been diagnosed with schizophrenia, bipolar disorder, or other mental disorders;
  • 3\) History of personality disorder;
  • 4\) History of alcohol or substance abuse;
  • 5\) History of brain trauma and epilepsy;
  • 6\) Patients with severe heart, liver, kidney and cerebrovascular diseases;
  • 7\) Chronic weakness, severe neurosis, dementia, severe osteoporosis, pregnancy;
  • 8\) Leukemia, thrombocytopenia and other bleeding tendency.

Outcomes

Primary Outcomes

Not specified

Similar Trials